These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28943978)

  • 1. Impact of targeted educational interventions on appropriateness of stress ulcer prophylaxis in critically ill adults.
    Hammond DA; Killingsworth CA; Painter JT; Pennick RE; Chatterjee K; Boye B; Meena N
    Pharm Pract (Granada); 2017; 15(3):948. PubMed ID: 28943978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of A Collaborative Strategy to Reduce the Inappropriate Use of Acid Suppressive Therapy in Non-Intensive Care Unit Patients.
    Belfield KD; Kuyumjian AG; Teran R; Amadi M; Blatt M; Bicking K
    Ann Pharmacother; 2017 Jul; 51(7):577-583. PubMed ID: 28622739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Targeted Educational Interventions on Clostridium difficile Infection Treatment in Critically Ill Adults.
    Hammond DA; Hughes CA; Painter JT; Pennick RE; Chatterjee K; Boye B; Meena N
    Hosp Pharm; 2016 Dec; 51(11):901-906. PubMed ID: 28057949
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of pharmacy resident led education on resident physician prescribing habits associated with stress ulcer prophylaxis in non-intensive care unit patients.
    Agee C; Coulter L; Hudson J
    Am J Health Syst Pharm; 2015 Jun; 72(11 Suppl 1):S48-52. PubMed ID: 25991596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overuse of Acid-Suppression Therapy at an Urban Tertiary Hospital.
    Redfern RE; Brown M; Karhoff KL; Middleton JL
    South Med J; 2015 Dec; 108(12):732-8. PubMed ID: 26630894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of inappropriate continuation of acid suppressive therapy after discharge in patients who began therapy in the surgical intensive care unit.
    Murphy CE; Stevens AM; Ferrentino N; Crookes BA; Hebert JC; Freiburg CB; Rebuck JA
    Pharmacotherapy; 2008 Aug; 28(8):968-76. PubMed ID: 18657013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An interprofessional approach to reducing the overutilization of stress ulcer prophylaxis in adult medical and surgical intensive care units.
    Tasaka CL; Burg C; VanOsdol SJ; Bekeart L; Anglemyer A; Tsourounis C; Rennke S
    Ann Pharmacother; 2014 Apr; 48(4):462-9. PubMed ID: 24473490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward.
    Khalili H; Dashti-Khavidaki S; Hossein Talasaz AH; Tabeefar H; Hendoiee N
    J Manag Care Pharm; 2010 Mar; 16(2):114-21. PubMed ID: 20178396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a clinical pharmacist stress ulcer prophylaxis management program on inappropriate use in hospitalized patients.
    Buckley MS; Park AS; Anderson CS; Barletta JF; Bikin DS; Gerkin RD; O'Malley CW; Wicks LM; Garcia-Orr R; Kane-Gill SL
    Am J Med; 2015 Aug; 128(8):905-13. PubMed ID: 25820164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-Initiated De-Prescribing Efforts Reduce Inappropriate Continuation of Acid-Suppression Therapy Initiated in the ICU.
    Cascone AE; Sullivan J; Ackerbauer K; Patel S; Lindale DK; Tatro H; Feeney ME
    Am J Med; 2023 Feb; 136(2):186-192. PubMed ID: 36170933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate continuation of stress ulcer prophylactic therapy after discharge.
    Wohlt PD; Hansen LA; Fish JT
    Ann Pharmacother; 2007 Oct; 41(10):1611-6. PubMed ID: 17848420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit.
    Masood U; Sharma A; Bhatti Z; Carroll J; Bhardwaj A; Sivalingam D; Dhamoon AS
    Inquiry; 2018; 55():46958018759116. PubMed ID: 29502481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization.
    Thomas L; Culley EJ; Gladowski P; Goff V; Fong J; Marche SM
    J Manag Care Pharm; 2010 Mar; 16(2):122-9. PubMed ID: 20178397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
    Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
    Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill Patients.
    Hong MT; Monye LC; Seifert CF
    Ann Pharmacother; 2015 Sep; 49(9):1004-8. PubMed ID: 26139638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress ulcer prophylaxis in hospitalized patients not in intensive care units.
    Grube RR; May DB
    Am J Health Syst Pharm; 2007 Jul; 64(13):1396-400. PubMed ID: 17592004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of costs accrued through inadvertent continuation of hospital-initiated proton pump inhibitor therapy for stress ulcer prophylaxis beyond hospital discharge: a retrospective chart review.
    Shin S
    Ther Clin Risk Manag; 2015; 11():649-57. PubMed ID: 26005351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Pharmacist-Led Impact on Inappropriate Albumin Use and Costs in the Critically Ill.
    Buckley MS; Knutson KD; Agarwal SK; Lansburg JM; Wicks LM; Saggar RC; Richards EC; Kopp BJ; Erstad BL
    Ann Pharmacother; 2020 Feb; 54(2):105-112. PubMed ID: 31544470
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of acid suppressive therapy in hospitalized non-critically ill patients.
    Sheikh-Taha M; Alaeddine S; Nassif J
    World J Gastrointest Pharmacol Ther; 2012 Dec; 3(6):93-6. PubMed ID: 23494814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of pharmacist interventions on correction of stress-related mucosal damage prophylaxis practice.
    Mahmoudi L; Mohammadi R; Niknam R
    Clinicoecon Outcomes Res; 2019; 11():111-116. PubMed ID: 30774401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.